We are live on ! Find out more
CVS icon

CVS Health

1,483 hedge funds and large institutions have $97.6B invested in CVS Health in 2015 Q2 according to their latest regulatory filings, with 89 funds opening new positions, 605 increasing their positions, 605 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more first-time investments, than exits

New positions opened: 89 | Existing positions closed: 48

4% more funds holding in top 10

Funds holding in top 10: 218227 (+9)

2% more funds holding

Funds holding: 1,4601,483 (+23)

7% more call options, than puts

Call options by funds: $464M | Put options by funds: $434M

1% more capital invested

Capital invested by funds: $96.9B → $97.6B (+$674M)

0% more repeat investments, than reductions

Existing positions increased: 605 | Existing positions reduced: 605

0.77% less ownership

Funds ownership: 83.7%82.93% (-0.77%)

Holders
1,483
Holders Change
+23
Holders Change %
+1.58%
% of All Funds
39.94%
Holding in Top 10
227
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+4.13%
% of All Funds
6.11%
New
89
Increased
605
Reduced
605
Closed
48
Calls
$464M
Puts
$434M
Net Calls
+$29.7M
Net Calls Change
-$54.4M
Name Holding Trade Value Shares
Change
Change in
Stake
MAA
26
Managed Account Advisors
New Jersey
$822M +$45.9M +449,139 +6%
Macquarie Group
27
Macquarie Group
Australia
$692M +$3.49M +34,116 +0.5%
ClearBridge Investments
28
ClearBridge Investments
New York
$676M -$26.2M -256,690 -4%
Invesco
29
Invesco
Georgia
$617M +$123M +1,201,552 +26%
Winslow Capital Management
30
Winslow Capital Management
Minnesota
$593M +$79.3M +776,412 +16%
EIP
31
Epoch Investment Partners
New York
$579M -$13.6M -132,666 -2%
AAMU
32
Amundi Asset Management US
Massachusetts
$576M +$4.44M +43,422 +0.8%
Harris Associates
33
Harris Associates
Illinois
$575M -$153K -1,500 -0%
JHIU
34
Janus Henderson Investors US
Colorado
$559M +$56.2M +550,351 +12%
AIM
35
abrdn Investment Management
United Kingdom
$553M -$51.3M -501,758 -9%
Deutsche Bank
36
Deutsche Bank
Germany
$528M +$7.23M +70,759 +1%
Bank of Montreal
37
Bank of Montreal
Ontario, Canada
$522M -$27.9M -273,474 -5%
UBS AM
38
UBS AM
Illinois
$511M +$44.1M +431,448 +10%
AQR Capital Management
39
AQR Capital Management
Connecticut
$504M +$96.3M +942,476 +24%
Legal & General Group
40
Legal & General Group
United Kingdom
$500M +$15.3M +149,652 +3%
PI
41
Putnam Investments
Massachusetts
$488M -$7.58M -74,158 -2%
FPA
42
First Pacific Advisors
California
$485M -$817K -8,000 -0.2%
BIM
43
BlackRock Investment Management
Delaware
$473M +$51.1M +500,491 +12%
UBS Group
44
UBS Group
Switzerland
$465M +$25.4M +248,994 +6%
Swedbank
45
Swedbank
Sweden
$458M +$22.7M +222,167 +5%
Goldman Sachs
46
Goldman Sachs
New York
$455M -$9.31M -91,134 -2%
VAM
47
Veritas Asset Management
United Kingdom
$432M -$5.48M -53,683 -1%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$406M +$8.34M +81,612 +2%
Allianz Asset Management
49
Allianz Asset Management
Germany
$404M +$40.8M +399,016 +12%
EVM
50
Eaton Vance Management
Massachusetts
$404M -$59.8M -585,304 -13%

CVS Hedge Fund Activity: Q2 2015 in Review

1,483 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q2 2015, worth a combined $97.6B — up 0.7% from $96.9B a quarter earlier.

Buyers outnumbered sellers: 89 funds opened new CVS positions and 48 closed out — a net gain of 41 holders — while 605 added to existing stakes and 605 trimmed.

The largest buyer was Ameriprise, adding an estimated $501M. The largest seller was JP Morgan Chase, cutting an estimated $779M.

  • 1,483 institutional investors held CVS Health (CVS) as of Q2 2015, up from 1,460 in Q1 2015.
  • Funds reported $97.6B of CVS Health stock for Q2 2015, up 0.7% quarter-over-quarter.
  • 89 funds opened new CVS Health positions in Q2 2015 and 48 closed out, a net change of +41 holders.
  • The largest CVS Health buyer in Q2 2015 was Ameriprise, an estimated $501M added.
  • The largest CVS Health seller in Q2 2015 was JP Morgan Chase, an estimated $779M sold.

Based on aggregated 13F filings for Q2 2015.